Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T, Neidhard EM, Vignard V, Lefeuvre C, Adamski H, Labarrière N, Carsin A, Monnier D, Collet B, Clapisson G, Birebent B, Philip I, Toujas L, Chokri M, Quillien V. Lesimple T, et al. Among authors: birebent b. Clin Cancer Res. 2006 Dec 15;12(24):7380-8. doi: 10.1158/1078-0432.CCR-06-1879. Clin Cancer Res. 2006. PMID: 17189411 Clinical Trial.
Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.
Birebent B, Somasundaram R, Purev E, Li W, Mitchell E, Hoey D, Bloom E, Mastrangelo M, Maguire H, Harris DT, Staib L, Braumuller H, Leeser C, Kuttner N, Beger HG, Herlyn D. Birebent B, et al. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):107-13. doi: 10.1016/s1040-8428(01)00125-1. Crit Rev Oncol Hematol. 2001. PMID: 11418307 Clinical Trial.
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients.
Birebent B, Mitchell E, Akis N, Li W, Somasundaram R, Purev E, Hoey D, Mastrangelo M, Maguire H, Harris DT, Nair S, Cai D, Zhang T, Herlyn DM. Birebent B, et al. Vaccine. 2003 Apr 2;21(15):1601-12. doi: 10.1016/s0264-410x(02)00752-1. Vaccine. 2003. PMID: 12639481
Colon cancer antigen and anti-idiotype vaccines.
Herlyn D, Birebent B, Akis N, Purev E, Somasundaram R, Mitchell E, Maguire H, Staib L, Mastrangelo M. Herlyn D, et al. Among authors: birebent b. Cancer Chemother Biol Response Modif. 2003;21:287-98. doi: 10.1016/s0921-4410(03)21014-0. Cancer Chemother Biol Response Modif. 2003. PMID: 15338751 No abstract available.
Advances in cancer vaccine development.
Herlyn D, Birebent B. Herlyn D, et al. Among authors: birebent b. Ann Med. 1999 Feb;31(1):66-78. doi: 10.3109/07853899909019264. Ann Med. 1999. PMID: 10219716 Free article. Review.
Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta.
Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S, Monos D, Peritt D, Marincola F, Cai D, Birebent B, Bloome E, Kim J, Berencsi K, Mastrangelo M, Herlyn D. Somasundaram R, et al. Among authors: birebent b. Cancer Res. 2002 Sep 15;62(18):5267-72. Cancer Res. 2002. PMID: 12234995
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.
Basak S, Birebent B, Purev E, Somasundaram R, Maruyama H, Zaloudik J, Swoboda R, Strittmatter W, Li W, Luckenbach A, Song H, Li J, Sproesser K, Guerry D, Nair S, Furukawa K, Herlyn D. Basak S, et al. Among authors: birebent b. Cancer Immunol Immunother. 2003 Mar;52(3):145-54. doi: 10.1007/s00262-002-0340-0. Epub 2003 Feb 11. Cancer Immunol Immunother. 2003. PMID: 12649743 Free PMC article.
34 results